Invaron Pharmaceuticals, a Canadian based company focuses on the acquisition of orphaned products registered in other countries for use by Canadians with rare diseases.
Clinical and Treatment Trial selection as bed side tool to help doctors, research nurses, research coordinators in selection of the trial that suites the best for patient with various medical conditions esp. cancer, genetic conditions
Orphan Insight Ltd was established to support the development and successful commercialisation of innovative therapies for the treatment of rare diseases where significant unmet clinical need exists.
The main objective of Rare Disease Day 2015 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
The main objective of Rare Disease Day 2015 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
The main objective of Rare Disease Day 2017 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
CORD is Canada's national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders. CORD works with governments
The Guthy-Jackson Charitable Foundation funds research to find answers to the prevention, clinical treatment programs and a potential cure for NMO (Neuromyelitis Optica).
The Guthy-Jackson Charitable Foundation funds research to find answers to the prevention, clinical treatment programs and a potential cure for NMO (Neuromyelitis Optica).
The main objective of Rare Disease Day 2015 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
The main objective of Rare Disease Day 2015 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
The main objective of Rare Disease Day 2018 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
The Guthy-Jackson Charitable Foundation funds research to find answers to the prevention, clinical treatment programs and a potential cure for NMO (Neuromyelitis Optica).
CORD is Canada's national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders. CORD works with governments
The European Network for the Study of Adrenal Tumors has recently implemented a collection of adrenal tumor related databases and defined an associated network of Biological Resource Centers devoted to research on adrenal tumors. The ultimate aim of the E
The Guthy-Jackson Charitable Foundation funds research to find answers to the prevention, clinical treatment programs and a potential cure for NMO (Neuromyelitis Optica).
The Guthy-Jackson Charitable Foundation funds research to find answers to the prevention, clinical treatment programs and a potential cure for NMO (Neuromyelitis Optica).
Niemann-Pick Childrens Fund, Inc. was organized in December of 2008 in order to raise awareness of Niemann-Pick Disease Type C and its affect on families in
The main objective of Rare Disease Day 2015 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
invaron.com
Helping Patients | Invaron Pharmaceuticals